Chemotherapy of Human Head and Neck Cancer Xenografts with Three Clinically Active Drugs: Cis-platinum, Bleomycin and Methotrexate

Overview

Journal Br J Cancer

Specialty Oncology

Date 1983 Nov 1

PMID 6196043

Citations 8

Authors

B J Braakhuis

E J Schoevers

E C Heinerman

G Sneeuwloper

G B Snow

Affiliations

Soon will be listed here.

Abstract

Human head and neck tumours were successfully transplanted in athymic nude mice. In 14 xenograft lines the effect of 1 to 3 clinically active agents could be tested. Maximum tolerated doses were given daily for 3-7 days. Growth delay was estimated in terms of the number of volume doubling times gained by the treatment. Cis-platinum and bleomycin appeared to be effective agents. In all 6 lines in which cis-platinum was examined, growth delay sometimes followed by complete regression was achieved. In 6/7 lines a response to bleomycin was observed. There was wide variation in sensitivity to cis-platinum and bleomycin among the different lines. Methotrexate, effective in 40-60% of patients with head and neck cancer, essentially showed no activity. Methotrexate produced a minimal growth delay in 1/11 lines treated. Two of the patients from whom xenografts were obtained responded to methotrexate treatment. The observed lack of activity of methotrexate against these tumour xenografts indicates that this model has limitations in the screening of new anticancer agents.

Citing Articles

The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer.

Boven E, Schipper H, Erkelens C, Hatty S, Pinedo H Br J Cancer. 1993; 68(1):52-6.

PMID: 8318420 PMC: 1968329. DOI: 10.1038/bjc.1993.285.

Successful in vitro growth of human head and neck cancer after transplantation in nude mice.

Heinerman E, Braakhuis B, Boerrigter G, Snow G Arch Otorhinolaryngol. 1985; 241(3):225-32.

PMID: 4040745 DOI: 10.1007/BF00453692.

Chemosensitivity of human head and neck cancer xenografts in the clonogenic assay and in nude mice.

Boerrigter G, Heinerman E, Braakhuis B, Snow G Br J Cancer. 1986; 54(1):53-9.

PMID: 3730256 PMC: 2001662. DOI: 10.1038/bjc.1986.151.

Sequence dependence of the antitumor and toxic effects of 5-fluorouracil and cis-diamminedichloroplatinum combination on primary colon tumors in mice.

Pratesi G, Gianni L, Manzotti C, Zunino F Cancer Chemother Pharmacol. 1988; 21(3):237-40.

PMID: 3359558 DOI: 10.1007/BF00262777.

Human tumor xenografts as model for drug testing.

Mattern J, Bak M, Hahn E, Volm M Cancer Metastasis Rev. 1988; 7(3):263-84.

PMID: 3067903 DOI: 10.1007/BF00047755.

References

LOONEY W, Mayo A, Allen P, Morrow J, MORRIS H . A mathematical evaluation of tumour growth curves in rapid, intermediate and slow growing rat hepatomata. Br J Cancer. 1973; 27(4):341-4. PMC: 2008786. DOI: 10.1038/bjc.1973.41. View

Shorthouse A, Jones J, STEEL G, Peckham M . Experimental combination and single-agent chemotherapy in human lung-tumour xenografts. Br J Cancer. 1982; 46(1):35-44. PMC: 2011054. DOI: 10.1038/bjc.1982.162. View

Povlsen C, Jacobsen G . Chemotherapy of a human malignant melanoma transplanted in the nude mouse. Cancer Res. 1975; 35(10):2790-6. View

Straw J, Talbot D, Taylor G, HARRAP K . Some observations on the reversibility of methotrexate toxicity in normal proliferating tissues. J Natl Cancer Inst. 1977; 58(1):91-7. DOI: 10.1093/jnci/58.1.91. View

Pesce A, Bubel H, DiPersio L, Michael J . Human lactic dehydrogenase as a marker for human tumor cells grown in athymic mice. Cancer Res. 1977; 37(7 Pt 1):1998-2003. View

Osieka R, Houchens D, Goldin A, Johnson R . Chemotherapy of human colon cancer xenografts in athymic nude mice. Cancer. 1977; 40(5 Suppl):2640-50. DOI: 10.1002/1097-0142(197711)40:5+<2640::aid-cncr2820400938>3.0.co;2-1. View

Carter S . The chemotherapy of head and neck cancer. Semin Oncol. 1977; 4(4):413-24. View

Nowak K, Peckham M, STEEL G . Variation in response of xenografts of colo-rectal carcinoma to chemotherapy. Br J Cancer. 1978; 37(4):576-84. PMC: 2009561. DOI: 10.1038/bjc.1978.87. View

HOUGHTON J, Houghton P . On the mechanism of cytotoxicity of fluorinated pyrimidines in four human colon adenocarcinoma xenografts maintained in immune-deprived mice. Cancer. 1980; 45(5 Suppl):1159-67. DOI: 10.1002/1097-0142(19800315)45:5+<1159::aid-cncr2820451320>3.0.co;2-z. View

10.

Shorthouse A, Smyth J, STEEL G, Ellison M, Mills J, Peckham M . The human tumour xenograft--a valid model in experimental chemotherapy?. Br J Surg. 1980; 67(10):715-22. DOI: 10.1002/bjs.1800671011. View

11.

Fujita M, Hayata S, Taguchi T . Relationship of chemotherapy on human cancer xenografts in nude mice to clinical response in donor patient. J Surg Oncol. 1980; 15(3):211-9. DOI: 10.1002/jso.2930150304. View

12.

Bailey M, Gazet J, Smith I, STEEL G . Chemotherapy of human breast-carcinoma xenografts. Br J Cancer. 1980; 42(4):530-6. PMC: 2010453. DOI: 10.1038/bjc.1980.276. View

13.

Kirkwood J, Canellos G, Ervin T, Pitman S, Weichselbaum R, Miller D . Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimen. Cancer. 1981; 47(10):2414-21. DOI: 10.1002/1097-0142(19810515)47:10<2414::aid-cncr2820471016>3.0.co;2-w. View

14.

DeConti R, Schoenfeld D . A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer. Cancer. 1981; 48(5):1061-72. DOI: 10.1002/1097-0142(19810901)48:5<1061::aid-cncr2820480502>3.0.co;2-x. View

15.

AZAR H, Fernandez S, Bros L, Sullivan J . Human tumor xenografts in athymic (nude) mice: chemotherapy trials in serially transplanted tumors. Ann Clin Lab Sci. 1982; 12(1):51-9. View

16.

Kopper L, STEEL G . The therapeutic response of three human tumor lines maintained in immune-suppressed mice. Cancer Res. 1975; 35(10):2704-13. View